BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 15838690)

  • 1. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin.
    Rubello D; Zavagno G; Bozza F; Lise M; De Salvo GL; Saladini G; Mariani G; Casara D
    Nucl Med Commun; 2004 Nov; 25(11):1119-24. PubMed ID: 15577591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.
    Sanjuàn A; Vidal-Sicart S; Zanón G; Pahisa J; Velasco M; Fernández PL; Santamaría G; Farrús B; Muñoz M; Albanell J; Pons F; Vanrell JA
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):932-6. PubMed ID: 15791433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection.
    Pelosi E; Baiocco C; Ala A; Gay E; Bello M; Varetto T; Giani R; Bussone R; Bisi G
    Nucl Med Commun; 2003 May; 24(5):519-23. PubMed ID: 12717068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of Tc-99m HIG and Tc-99m nanocolloid on sentinel lymph node mapping in patients with breast cancer.
    Yalçin H; Gençoglu EA; Yagmurdur M; Aras M; Ozen A; Aktas A
    Nucl Med Commun; 2010 Oct; 31(10):903-9. PubMed ID: 20683362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
    Mudun A; Sanli Y; Ozmen V; Turkmen C; Ozel S; Eroglu A; Igci A; Yavuz E; Tuzlali S; Muslumanoglu M; Cantez S
    Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in breast cancer: an analysis of the maximum number of nodes requiring excision.
    Gill J; Lovegrove R; Naessens K; Pursell R; Cominos T; McCormick C; Umeh H; Courtney S; Smith B
    Breast J; 2011; 17(1):3-8. PubMed ID: 21129088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.